Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
MD-Shoulder is an injectable collagen-based medical device developed by Guna S.p.a. intended to improve joint mobility and reduce pain in the shoulder. It belongs to a specialized line of collagen medical devices that provide a mechanical scaffold to support and stabilize the extra-cellular matrix of connective tissues. By reinforcing tendons, ligaments, and joint capsules, it helps to counteract the physiological or pathological degeneration of tissues in conditions like Rotator Cuff Syndrome, tendinopathy, and shoulder osteoarthritis. The formulation typically consists of porcine collagen combined with auxiliary botanical substances such as *Iris versicolor* to facilitate its application. It is administered via periarticular, intra-articular, or intramuscular injection to promote structural recovery and functional rehabilitation.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on MD-Shoulder.